TCM
HRMY icon

Tieton Capital Management’s Harmony Biosciences HRMY Stock Holding History

Tieton Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Sell
306,781
-4,715
-2% -$149K 3.21% 16
2026
Q1 		$8.72M Buy
311,496
+14,415
+5% +$473K 2.92% 21
2025
Q4 		$11.1M Sell
297,081
-1,510
-0.5% -$49.6K 3.8% 10
2025
Q3 		$8.23M Buy
298,591
+60,865
+26% +$2.1M 2.86% 19
2025
Q2 		$7.51M Buy
+237,726
New +$7.65M 2.94% 16

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tieton Capital Management's HRMY Position: Q2 2026 in Review

Tieton Capital Management reduced its Harmony Biosciences (HRMY) stake by 1.5% in Q2 2026, selling an estimated $149K and leaving 306,781 shares worth $11.2M. The position accounts for 3.21% of the portfolio, ranked #16.

Tieton Capital Management first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Tieton Capital Management held 306,781 shares of Harmony Biosciences worth $11.2M as of Q2 2026.
  • Tieton Capital Management sold 4,715 Harmony Biosciences shares in Q2 2026, an estimated $149K.
  • Harmony Biosciences made up 3.21% of Tieton Capital Management's portfolio in Q2 2026, its #16 holding.
  • Tieton Capital Management first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Tieton Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.